Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustaqeem

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
ACS Omega|January 23, 2023
Design, Synthesis, <i>In Vivo</i>, and <i>In Silico</i> Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic AgentsBharti Chauhan, Rajnish Kumar, Salahuddin, et al.
Plos One|June 5, 2020
A facile sonochemical protocol for synthesis of 3-amino- and 4-amino-1,2,4-triazole derived Schiff bases as potential antibacterial agentsAeysha Sultan, Mian Habib Ur Rehman, Noreen Sajjad, et al.
Vascular Medicine (London, England)|April 22, 2017
Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysisAriela L Marshall, Adam C Bartley, Aneel A Ashrani, et al.
Journal of Health Economics and Outcomes Research|July 22, 2024
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf CountriesAnas Hamad, Shereen Al-Azzazy, Ruba Y Taha, et al.
Molecules (Basel, Switzerland)|August 12, 2023
In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor AgentsMediha Assad, Rizwan Nasir Paracha, Abu Bakar Siddique, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Heliyon|December 24, 2024
Thermodynamic and kinetic insights into azo dyes photocatalytic degradation on biogenically synthesized ZnO nanoparticles and their antibacterial potentialAbu Bakar Siddique, Muhammad A Shaheen, Azhar Abbas, et al.
Plant Diversity|July 30, 2025
Multifaceted plant diversity patterns across the Himalaya: Status and outlookMustaqeem Ahmad, Ya-Huang Luo, Sonia Rathee, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
ACS Omega|January 23, 2023
Design, Synthesis, <i>In Vivo</i>, and <i>In Silico</i> Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic AgentsBharti Chauhan, Rajnish Kumar, Salahuddin, et al.
Plos One|June 5, 2020
A facile sonochemical protocol for synthesis of 3-amino- and 4-amino-1,2,4-triazole derived Schiff bases as potential antibacterial agentsAeysha Sultan, Mian Habib Ur Rehman, Noreen Sajjad, et al.
Vascular Medicine (London, England)|April 22, 2017
Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysisAriela L Marshall, Adam C Bartley, Aneel A Ashrani, et al.
Journal of Health Economics and Outcomes Research|July 22, 2024
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf CountriesAnas Hamad, Shereen Al-Azzazy, Ruba Y Taha, et al.
Molecules (Basel, Switzerland)|August 12, 2023
In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor AgentsMediha Assad, Rizwan Nasir Paracha, Abu Bakar Siddique, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Heliyon|December 24, 2024
Thermodynamic and kinetic insights into azo dyes photocatalytic degradation on biogenically synthesized ZnO nanoparticles and their antibacterial potentialAbu Bakar Siddique, Muhammad A Shaheen, Azhar Abbas, et al.
Plant Diversity|July 30, 2025
Multifaceted plant diversity patterns across the Himalaya: Status and outlookMustaqeem Ahmad, Ya-Huang Luo, Sonia Rathee, et al.
Pageof 16